查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828153

2025年儿科介入性心臟病学全球市场报告

Pediatric Interventional Cardiology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，儿科介入性心臟病学市场规模强劲成长，从2024年的24.4亿美元增加至2025年的26亿美元，复合年增长率为6.3%。预测期内的成长可归因于人们对霉菌毒素认识的提高、监管标准更加严格、对动物健康的关注、家禽生产的全球化、市场竞争力的提升以及农场生产力的提高。

预计未来几年儿科介入性心臟病学市场规模将强劲成长，到2029年将达到35.9亿美元，复合年增长率为8.4%。预测期内的成长可归因于家禽业的成长、气候变迁的影响、对有机产品的需求、全球贸易动态、政府倡议以及日益增强的健康意识。预测期内的主要趋势包括技术整合、饲料品质和安全、市场整合、合作研究、农业数位化以及饲料技术的进步。

小儿介入性心臟病学利用心导管手术，以微创方式诊断和治疗儿童先天性心臟疾病。这些手术旨在以最小的外科干预治疗各种心臟疾病。

儿童介入性心臟病学的关键器械包括封堵器、经导管心臟瓣膜、动脉粥状硬化斑块切除术器、导管、球囊和支架。闭合装置包含多种配件，当它们被紧紧固定在闭合位置时，可以密封血管内或其外部的开口，从而减轻或防止排放。儿童介入性心臟病学的关键程序包括导管瓣膜植入术、先天性心臟疾病矫正术、血管成形术、冠状动脉血栓切除术和其他方法。这些程序应用于临床实验室、医院、心臟中心、儿科诊所和研究机构，对儿童心臟病的诊断和治疗做出了重要贡献。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供儿科介入心臟病学市场统计数据，例如全球市场规模、区域份额、儿科介入心臟病学市场份额的竞争对手、详细的儿科机构心臟病学细分市场、市场趋势和机会，以及您在儿科介入行业取得成功所需的数据。这份儿科介入心臟病学市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年8.4%的预测成长率比我们先前对该市场的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响将直接影响美国，导致主要从荷兰和日本进口的导管导引线和球囊扩张型支架成本上升，并可能影响儿童微创心血管手术。此外，由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛。

随着先天性心臟疾病（一种从出生起就影响心臟结构的疾病）的发生率不断上升，儿科介入性心臟病学市场可望持续成长。与传统的开心手术相比，这些手术具有恢復更快、感染风险更低、疤痕更小等优势。根据美国心臟协会 2022 年的数据，美国约有 4 万名婴儿将患有先天性心臟疾病，预计每 1,000 名活产婴儿中就有 12.3 名患有先天性心臟病。此外，《柳叶刀》在 2022 年报告称，先天性心臟疾病是最常见的出生缺陷，每 1,000 名新生儿中就有近 9 名患有先天性心臟病。预计这种患病率将推动儿科介入性心臟病学市场的成长。

未来几年，儿科族群将推动儿科介入性心臟病学市场的发展。儿科族群指的是特定年龄层的个体，通常指儿童期和青少年期。根据联邦儿童与家庭统计跨部门论坛的数据，预计到2022年，美国儿童数将达到约7,250万，到2050年将达到7,820万。预计各年龄层人口的不断增长将推动儿科介入性心臟病学手术的需求。

产品创新是儿科介入性心臟病学市场的关键趋势。该领域的主要企业正在推出新的创新解决方案，以增强其市场占有率。例如，2023 年 2 月，美国医疗设备製造商美敦力公司推出了 Harmony 经导管肺动脉瓣系统，这是一款经导管肺动脉瓣。该系统作为开胸手术的微创替代方案，可透过腿部或颈部的小切口植入。 Harmony TPV 系统专为接受过先天性心臟疾病手术且因先前植入的导管或生物假体肺动脉瓣而导致右心室流出道 (RVOT) 功能障碍的患者设计。它也适用于需要进行肺动脉瓣置换术的天然或贴片右心室流出道患者。

为了确保竞争优势，儿科介入性心臟病学市场的主要企业正在优先开发3D食道超音波心动图 (3D TEE) 等技术创新。在儿科介入性心臟病学中，即时 3D TEE 可提供先天性心臟疾病的复杂影像，包括心房中隔缺损和心室中隔缺损，这使其成为规划和指导微创手术的关键。例如，2024 年 1 月，总部位于荷兰的医疗技术公司飞利浦推出了 X11-4T Mini 3D TEE 换能器。这种尖端换能器透过提供诊断儿科先天性心臟疾病所必需的详细影像，增强了3D食道超音波心动图 (TEE)。其显着特点包括紧凑的设计，可提高儿科患者的可操作性，高解析度成像功能，可提高诊断准确性，并可与现有的超音波心动图系统相容，实现无缝的工作流程。这些进步将显着改善儿科循环系统领域的治疗结果和患者照护。

2022年2月，美国知名生物医学和生物技术公司波士顿科学公司（Boston Scientific Corporation）以约17.5亿美元的价格完成了对贝利斯医疗公司的收购。这项策略性倡议旨在巩固波士顿科学公司在心臟病学市场的地位，尤其是在提供基于导管的左心室手术先进解决方案方面。贝利斯医疗公司也总部位于美国，专注于心臟病学、血管内治疗和肿瘤学等高科技领域的尖端医疗设备。

儿科介入心臟病学市场的主要企业包括美敦力公司、通用电气医疗技术公司、雅培实验室、泰尔茂​​公司、戈尔公司、波士顿科学公司、爱德华生命科学公司、西门子医疗、Numed公司、圣犹达医疗公司、Cordis公司、荷兰皇家飞利浦公司、百多力、B. Braips NV、百多力、B. Braunsungen AG、佳能医疗系统公司、戈尔公司、强生公司、库克集团、泰利福公司、Merit医疗系统公司、微创医疗科学公司、乐普医疗技术（北京）有限公司、柏盛国际集团有限公司、心臟科学公司、朝日Intecc公司、Medinol有限公司、Jotec有限公司、Hexacath有限公司和Translumina有限公司

2024年，北美是儿科介入性心臟病学市场最大的地区。预计在预测期内，亚太地区将成为全球儿科介入性心臟病学市场成长最快的地区。儿科介入性心臟病学市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

儿科介入性心臟病学市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙

儿科介入性心臟病学市场包括营业单位从经皮冠状动脉介入治疗服务、心房中膈缺损症服务、心导管插入术服务和经导管主动脉瓣置换服务中产生的收益。市场价值包括服务提供者销售的或包含在服务产品中的相关商品的价值。仅包括在企业之间交易或出售给最终消费者的商品和服务。儿科介入性心臟病学市场还包括斑块修改装置、导管导引线、血管闭合装置和动脉粥状硬化斑块切除术硬化切除装置的销售。该市场中的价值是「工厂门口」价值，即商品製造商或生产商直接向其他营业单位（包括下游製造商、批发商、经销商和零售商）或最终消费者销售的商​​品价值。该市场中的商品价值也包括商品製造商销售的相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球儿科介入性心臟病学：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球儿科介入性心臟病学市场：成长率分析
  • 全球儿科介入性心臟病学市场表现：规模与成长，2019-2024
  • 全球儿科介入性心臟病学市场预测：规模与成长，2024-2029年，2034年
  • 全球儿科介入性心臟病学：总目标市场（TAM）

第六章 市场细分

  • 全球儿科介入性心臟病学市场（按设备类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 封闭装置
  • 经导管心臟瓣膜
  • 动脉粥状硬化斑块切除术切除装置
  • 导管
  • 气球
  • 支架
  • 其他设备类型
  • 全球儿科介入性心臟病学市场（按程序、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 导管辅助瓣膜植入
  • 先天性心臟疾病的矫正
  • 血管成形术
  • 冠状动脉血栓切除术
  • 其他措施
  • 全球儿科介入性心臟病学市场最终用途、绩效及预测（2019-2024、2024-2029、2034）
  • 临床检测实验室
  • 医院
  • 心臟中心
  • 小儿科诊所
  • 研究所
  • 全球儿科介入性心臟病学市场：按封堵器细分（按类型）、业绩及预测，2019-2024 年、2024-2029 年、2034 年
  • 心房间隔缺损 (ASD) 封堵器
  • 室间隔缺损 (VSD) 封堵器
  • 开放性动脉导管(PDA) 封堵器
  • 全球儿科介入性心臟病学市场：经导管心臟瓣膜细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 经导管主动脉瓣置换术（TAVR）装置
  • 经导管二尖瓣瓣膜修復装置
  • 经导管肺动脉瓣置换装置
  • 全球儿科介入性心臟病学市场：动脉粥状动脉粥状硬化斑块切除术设备细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 定向动脉粥状硬化斑块切除术装置
  • 旋动脉粥状硬化斑块切除术装置
  • 雷射动脉粥状硬化斑块切除术装置
  • 全球儿科介入性心臟病学市场：导管细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断导管
  • 治疗导管
  • 引导管
  • 全球儿科介入性心臟病学市场：按球囊类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 球囊血管成形术球囊
  • 主动脉内球囊
  • 高压气球
  • 全球儿科介入性心臟病学市场：按支架类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 药物释放型支架
  • 裸金属支架
  • 生物可吸收支架
  • 全球儿科介入性心臟病学市场：按设备类型（其他）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血管闭合装置
  • 血流动力学监测装置
  • 电生理学设备

第七章 区域和国家分析

  • 全球儿科介入性心臟病学市场各地区、业绩及预测（2019-2024、2024-2029、2034）
  • 全球儿科介入性心臟病学市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 儿科介入性心臟病学市场：竞争格局
  • 儿科介入性心臟病学市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • WL Gore & Associates Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Siemens Healthineers
  • Numed Inc.
  • St. Jude Medical Inc.
  • Cordis Corporation
  • Koninklijke Philips NV
  • Biotronik
  • B. Braun Melsungen AG
  • Canon Medical Systems Corporation
  • Gore & Associates Inc.
  • Johnson and Johnson
  • Cook Group LLC
  • Teleflex Incorporated
  • Merit Medical Systems Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年儿科介入心臟病学市场：提供新机会的国家
  • 2029年儿科介入性心臟病学市场：细分领域带来新机会
  • 2029年儿科介入性心臟病学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24398u

Pediatric interventional cardiology involves utilizing cardiac catheterization in children to both diagnose and treat congenital heart defects through minimally invasive procedures. These procedures aim to address various heart conditions while minimizing surgical invasiveness.

Key devices within pediatric interventional cardiology encompass closure devices, trans catheter heart valves, atherectomy devices, catheters, balloons, stents, among others. Closure devices encompass a range of fittings that, when securely fastened in a closed position, mitigate or prevent air emissions by sealing openings in containers or their exteriors. The primary procedures in pediatric interventional cardiology involve catheter-based valve implantation, correction of congenital heart defects, angioplasty, coronary thrombectomy, and other methodologies. These procedures find application in clinical testing labs, hospitals, cardiac centers, pediatric clinics, and research institutions, contributing significantly to diagnosing and managing cardiac conditions in children.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The pediatric interventional cardiology market research report is one of a series of new reports from The Business Research Company that provides pediatric interventional cardiology market statistics, including pediatric interventional cardiology industry global market size, regional shares, competitors with a pediatric interventional cardiology market share, detailed pediatric interventional cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric interventional cardiology industry. This pediatric interventional cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric interventional cardiology market size has grown strongly in recent years. It will grow from $2.44 billion in 2024 to $2.6 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased mycotoxin awareness, stringent regulatory standards, focus on animal health, globalization of poultry production, market competitiveness, increased farm productivity.

The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.59 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing poultry industry, climate change impacts, demand for organic products, global trade dynamics, government initiatives, increasing health consciousness. Major trends in the forecast period include integration of technology, feed quality and safety, market consolidation, collaborative research efforts, digitalization in agriculture, advancements in feed technology.

The forecast of 8.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher expenses for micro-guidewires and balloon-expandable stents, largely imported from the Netherlands and Japan, affecting minimally invasive cardiac procedures for children.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The pediatric interventional cardiology market is poised for growth due to the increasing prevalence of congenital heart disease, a condition affecting the heart's structure since birth. These procedures offer advantages over traditional open-heart surgery, including quicker recovery, reduced infection risks, and minimized scarring. According to the American Heart Association in 2022, around 40,000 infants in the U.S. are affected by congenital heart defects, with an estimated birth prevalence of 12.3 per 1000 in the country. Additionally, The Lancet reported in 2022 that congenital heart disease is the most common birth defect, impacting nearly 9 out of every 1000 live births. This prevalence is expected to drive the growth of the pediatric interventional cardiology market.

Pedistric population drives the pediatric interventional cardiology market going forward. This demographic refers to individuals within specific age brackets typically associated with childhood and adolescence. According to the Federal Interagency Forum on Child and Family Statistics, the U.S. had around 72.5 million children in 2022, projected to reach 78.2 million by 2050. The rise in this population, spanning different age groups, is expected to fuel the demand for pediatric interventional cardiology procedures.

Product innovation is a significant trend in the pediatric interventional cardiology market. Leading companies in this field are introducing new and creative solutions to enhance their market presence. For example, in February 2023, Medtronic plc., a U.S.-based medical devices company, launched the Harmony Transcatheter Pulmonary Valve System, a transcatheter pulmonary valve. This system serves as a minimally invasive alternative to open-heart surgery and can be implanted through a small incision in the leg or neck. The Harmony TPV system is designed for patients who have previously undergone surgery for congenital heart disease and are experiencing a dysfunctional right ventricular outflow tract (RVOT) due to an earlier implanted conduit or bioprosthetic pulmonary valve. It is also indicated for patients with a native or patched RVOT who need a pulmonary valve replacement.

Major companies in the pediatric interventional cardiology market are prioritizing the development of technological innovations, such as three-dimensional transesophageal echocardiography (3D TEE), to secure a competitive advantage. In pediatric interventional cardiology, real-time 3D TEE provides intricate images of congenital heart defects, including atrial and ventricular septal defects, which are vital for planning and guiding minimally invasive procedures. For example, in January 2024, Philips, a healthcare technology company based in the Netherlands, launched the X11-4T Mini 3D TEE transducer. This state-of-the-art transducer enhances three-dimensional transesophageal echocardiography (TEE) by delivering detailed imaging essential for diagnosing congenital heart defects in children. Notable features include its compact design, which improves maneuverability in pediatric patients, high-resolution imaging capabilities that boost diagnostic accuracy, and compatibility with existing echocardiography systems for a seamless workflow. These advancements substantially enhance procedural outcomes and patient care within pediatric cardiology.

In February 2022, Boston Scientific Corporation, a prominent U.S. biomedical and biotechnology firm, completed the acquisition of Baylis Medical Company Inc. for an estimated $1.75 billion. This strategic move is aimed at fortifying Boston Scientific Corporation's standing within the cardiology markets, specifically by enhancing its offerings in advanced solutions for catheter-based left-heart procedures. Baylis Medical Company Inc., also based in the U.S., specializes in cutting-edge medical devices operating within high-technology cardiology, endovascular, and oncology realms.

Major companies operating in the pediatric interventional cardiology market include Medtronic plc, GE HealthCare Technologies Inc., Abbott Laboratories, Terumo Corporation, W.L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Siemens Healthineers, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Canon Medical Systems Corporation, Gore & Associates Inc., Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co.Ltd., Biosensors International Group Ltd., Cardiac Science Corporation, Asahi Intecc Co.Ltd., Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH

North America was the largest region in the pediatric interventional cardiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric interventional cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pediatric interventional cardiology market includes revenues earned by entities by percutaneous coronary intervention services, atrial septal defect services, cardiac catheterization services, and trans catheter aortic valve replacement services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pediatric interventional cardiology market also consists of sales of plaque modification devices, guide wire, vascular closure devices, and atherectomy device. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Interventional Cardiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric interventional cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric interventional cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric interventional cardiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Closure Devices; Trans catheter Heart Valves; Atherectomy Devices; Catheters; Balloons; Stents; Other Device Types
  • 2) By Procedure: Catheter-Based Valve Implantation; Congenital Heart Defect Correction; Angioplasty; Coronary Thrombectomy; Other Procedures
  • 3) By End-Use: Clinical Testing Laboratories; Hospitals; Cardiac Centers; Pediatric Clinics; Research Institutions
  • Subsegments:
  • 1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices; Ventricular Septal Defect (VSD) Closure Devices; Patent Ductus Arteriosus (PDA) Closure Devices
  • 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR) Devices; Transcatheter Mitral Valve Repair Devices; Transcatheter Pulmonary Valve Replacement Devices
  • 3) By Atherectomy Devices: Directional Atherectomy Devices; Rotational Atherectomy Devices; Laser Atherectomy Devices
  • 4) By Catheters: Diagnostic Catheters; Therapeutic Catheters; Guiding Catheters
  • 5) By Balloons: Balloon Angioplasty Balloons; Intra-Aortic Balloons; High-Pressure Balloons
  • 6) By Stents: Drug-Eluting Stents; Bare-Metal Stents; Bioresorbable Stents
  • 7) By Other Device Types: Vascular Closure Devices; Hemodynamic Monitoring Devices; Electrophysiology Devices
  • Companies Mentioned: Medtronic plc; GE HealthCare Technologies Inc.; Abbott Laboratories; Terumo Corporation; W.L. Gore & Associates Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Siemens Healthineers; Numed Inc.; St. Jude Medical Inc.; Cordis Corporation; Koninklijke Philips N.V.; Biotronik; B. Braun Melsungen AG; Canon Medical Systems Corporation; Gore & Associates Inc.; Johnson and Johnson; Cook Group LLC; Teleflex Incorporated; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Lepu Medical Technology (Beijing) Co.Ltd.; Biosensors International Group Ltd.; Cardiac Science Corporation; Asahi Intecc Co.Ltd.; Medinol Ltd.; Jotec GmbH; Hexacath Ltd.; Translumina GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pediatric Interventional Cardiology Market Characteristics

3. Pediatric Interventional Cardiology Market Trends And Strategies

4. Pediatric Interventional Cardiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pediatric Interventional Cardiology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pediatric Interventional Cardiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pediatric Interventional Cardiology Market Growth Rate Analysis
  • 5.4. Global Pediatric Interventional Cardiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pediatric Interventional Cardiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pediatric Interventional Cardiology Total Addressable Market (TAM)

6. Pediatric Interventional Cardiology Market Segmentation

  • 6.1. Global Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Closure Devices
  • Trans catheter Heart Valves
  • Atherectomy Devices
  • Catheters
  • Balloons
  • Stents
  • Other Device Types
  • 6.2. Global Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter-Based Valve Implantation
  • Congenital Heart Defect Correction
  • Angioplasty
  • Coronary Thrombectomy
  • Other Procedures
  • 6.3. Global Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Testing Laboratories
  • Hospitals
  • Cardiac Centers
  • Pediatric Clinics
  • Research Institutions
  • 6.4. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Closure Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect (ASD) Closure Devices
  • Ventricular Septal Defect (VSD) Closure Devices
  • Patent Ductus Arteriosus (PDA) Closure Devices
  • 6.5. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Aortic Valve Replacement (TAVR) Devices
  • Transcatheter Mitral Valve Repair Devices
  • Transcatheter Pulmonary Valve Replacement Devices
  • 6.6. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Atherectomy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Directional Atherectomy Devices
  • Rotational Atherectomy Devices
  • Laser Atherectomy Devices
  • 6.7. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Catheters
  • Therapeutic Catheters
  • Guiding Catheters
  • 6.8. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Angioplasty Balloons
  • Intra-Aortic Balloons
  • High-Pressure Balloons
  • 6.9. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioresorbable Stents
  • 6.10. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vascular Closure Devices
  • Hemodynamic Monitoring Devices
  • Electrophysiology Devices

7. Pediatric Interventional Cardiology Market Regional And Country Analysis

  • 7.1. Global Pediatric Interventional Cardiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pediatric Interventional Cardiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Interventional Cardiology Market

  • 8.1. Asia-Pacific Pediatric Interventional Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Interventional Cardiology Market

  • 9.1. China Pediatric Interventional Cardiology Market Overview
  • 9.2. China Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Interventional Cardiology Market

  • 10.1. India Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Interventional Cardiology Market

  • 11.1. Japan Pediatric Interventional Cardiology Market Overview
  • 11.2. Japan Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Interventional Cardiology Market

  • 12.1. Australia Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Interventional Cardiology Market

  • 13.1. Indonesia Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Interventional Cardiology Market

  • 14.1. South Korea Pediatric Interventional Cardiology Market Overview
  • 14.2. South Korea Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Interventional Cardiology Market

  • 15.1. Western Europe Pediatric Interventional Cardiology Market Overview
  • 15.2. Western Europe Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Interventional Cardiology Market

  • 16.1. UK Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Interventional Cardiology Market

  • 17.1. Germany Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Interventional Cardiology Market

  • 18.1. France Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Interventional Cardiology Market

  • 19.1. Italy Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Interventional Cardiology Market

  • 20.1. Spain Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Interventional Cardiology Market

  • 21.1. Eastern Europe Pediatric Interventional Cardiology Market Overview
  • 21.2. Eastern Europe Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Interventional Cardiology Market

  • 22.1. Russia Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Interventional Cardiology Market

  • 23.1. North America Pediatric Interventional Cardiology Market Overview
  • 23.2. North America Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Interventional Cardiology Market

  • 24.1. USA Pediatric Interventional Cardiology Market Overview
  • 24.2. USA Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Interventional Cardiology Market

  • 25.1. Canada Pediatric Interventional Cardiology Market Overview
  • 25.2. Canada Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Interventional Cardiology Market

  • 26.1. South America Pediatric Interventional Cardiology Market Overview
  • 26.2. South America Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Interventional Cardiology Market

  • 27.1. Brazil Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Interventional Cardiology Market

  • 28.1. Middle East Pediatric Interventional Cardiology Market Overview
  • 28.2. Middle East Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Interventional Cardiology Market

  • 29.1. Africa Pediatric Interventional Cardiology Market Overview
  • 29.2. Africa Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Interventional Cardiology Market Competitive Landscape And Company Profiles

  • 30.1. Pediatric Interventional Cardiology Market Competitive Landscape
  • 30.2. Pediatric Interventional Cardiology Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. W.L. Gore & Associates Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Interventional Cardiology Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Edwards Lifesciences Corporation
  • 31.3. Siemens Healthineers
  • 31.4. Numed Inc.
  • 31.5. St. Jude Medical Inc.
  • 31.6. Cordis Corporation
  • 31.7. Koninklijke Philips N.V.
  • 31.8. Biotronik
  • 31.9. B. Braun Melsungen AG
  • 31.10. Canon Medical Systems Corporation
  • 31.11. Gore & Associates Inc.
  • 31.12. Johnson and Johnson
  • 31.13. Cook Group LLC
  • 31.14. Teleflex Incorporated
  • 31.15. Merit Medical Systems Inc.

32. Global Pediatric Interventional Cardiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Interventional Cardiology Market

34. Recent Developments In The Pediatric Interventional Cardiology Market

35. Pediatric Interventional Cardiology Market High Potential Countries, Segments and Strategies

  • 35.1 Pediatric Interventional Cardiology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pediatric Interventional Cardiology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pediatric Interventional Cardiology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer